4th International Conference on Drug Discovery, Development and Lead Optimization
San Francisco, California
8:0am - 4:0pm
Drug Discovery-2018 will bring together experts working in the pharmaceutical industry, academic institutes and service organizations to discuss the latest advances in the design and methods for drug lead validation and optimization and novel drug target identification with and view to global healthcare goals and addressing for future needs.
The three-day conference is organized into four thematic symposia, led by a plenary presentation and keynote addresses that frame the topics and goals of the conference symposia. Speakers in the four symposia will address: Accelerating drug discovery and development through academic collaborations, target validation and lead optimization, RNA as a drug, drug target and gene editing tool in target validation and drug target discovery in rare diseases. Opportunities for short talks and poster opportunities are available
The anticipated outcome of this conference is to share expertise and experiences in an environment of learning that will promote engagement of scientists at the highest level in drug lead development through an awareness of opportunities from drug discovery, the application of technology for proof-of-concept along a critical path and advances in technology and feasibility of future drug development opportunities. The meeting seeks to foster communication and collaborations that will accelerate ideation and innovation in drug discovery and development.
Contact: Satish Noolu
Contact Phone: 4084264833
Contact Email: firstname.lastname@example.org
DoubleTree by Hilton San Francisco International Airport
835 Airport Blvd, Burlingame
CA 94010, United States